News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI
Dec 25, 2024, 14:47

Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a recent article on X:

“Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI in Radiology.”

Title: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Authors: Giorgio Brembilla , Giuseppe Basile, Michele Cosenza, Francesco Giganti, Andrea Del Prete, Tommaso Russo, Renato Pennella, Salvatore Lavalle, Daniele Raggi, Chiara Mercinelli, Valentina Tateo, Antonio Cigliola, Damiano Patanè, Emanuele Crupi, Patrizia Giannatempo, Antonella Messina, Giuseppina Calareso, Alberto Martini, Marco Bandini, Marco Moschini, Gianpiero Cardone, Alberto Briganti, Francesco Montorsi, Andrea Necchi and Francesco De Cobelli

Andrea Necchi

“Are you searching for the largest study on VIRADS?

Here is the Christmas gift from Giorgio Brembilla.”

More posts featuring Andrea Necchi.

Andrea Del Prete Andrea Necchi bladder cancer cancer chemotherapy Francesco De Cobelli Francesco Giganti Giorgio Brembilla Giuseppe Basile immunotherapy Michele Cosenza MRI OncoDaily Oncology Radiology
Special Coverage
Science
Dec 25, 2024, 14:47
Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI
Science
Dec 25, 2024, 14:44
Hung Trinh's review on breakthrough of solid tumor treatment: CAR-NK immunotherapy
Science
Dec 25, 2024, 14:43
Rachit Khandelwal: P-I-M with CD19 CAR-T therapy linked to reduced survival in hematologic malignancies
Insight
Dec 25, 2024, 14:09
Dr John Thompson Retires After 40 Years of Service at Fred Hutchinson Cancer Center
Celebrities
Dec 25, 2024, 14:05
Melanie Griffith and Skin Cancer: How She Went Against, How She Survived, and More
Blog
Dec 25, 2024, 14:04
Exploring Advances in ADA-SCID Gene Therapy: An Interview with Dr. Donald Kohn
Science
Dec 25, 2024, 13:55
Juan Gómez Rivas: Are prostate cancer guidelines meeting quality standards?
Science
Dec 25, 2024, 13:50
Yüksel Ürün: Shaping the future of survivorship in CSI Testicular GCT
Blog
Dec 25, 2024, 13:45
Lung Cancer Considered's new episode on Tumor Treating Fields - IASLC
Insight
Dec 25, 2024, 13:38
Year in Review: American Association for Cancer Research
Blog
Dec 25, 2024, 13:29
Sanjay Popat: Time to reflect on a year of treatment advances, teaching, and friendship
Blog
Dec 25, 2024, 13:24
Christina Curtis' work on integrative breast cancer subtypes at SABCS24